I

Iterum Therapeutics plc
D

ITRM

1.36000
USD
-0.05
(-3.55%)
مغلق
حجم التداول
15,952
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
30,880,152
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ADMP
    0
    (0%)
    0.000000 USD
    B
    BCRX
    -0.19000
    (-2.61%)
    7.10000 USD
    C
    CPRX
    -0.315
    (-1.83%)
    16.925 USD
    E
    EYPT
    -0.75000
    (-7.58%)
    9.14000 USD
    M
    MBRX
    -0.85000
    (-27.51%)
    2.24000 USD
    P
    PRPH
    -0.02000
    (-0.65%)
    3.04000 USD
    P
    PTN
    -0.03000
    (-1.79%)
    1.65000 USD
    T
    TNXP
    0.00960
    (1.92%)
    0.51050 USD
    المزيد
الأخبار
المقالات

العنوان: Iterum Therapeutics plc

القطاع: Healthcare
الصناعة: Biotechnology
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.